Combined Application of Xymedon Hydrochloride with Rabies Vaccine on the Background of Immunosupression
- Autores: Kalmykova Y.V.1, Akhmadeev R.M.1, Efimova M.A.1, Murtazina G.K.2, Papunidi K.K.1, Chernov A.N.1, Sagdeeva G.D.1
-
Afiliações:
- Federal Center for Toxicologic, Radiative, and Biologic Safety
- Kazan State Medical University
- Edição: Volume 44, Nº 3 (2018)
- Páginas: 282-286
- Seção: Veterinary
- URL: https://bakhtiniada.ru/1068-3674/article/view/230481
- DOI: https://doi.org/10.3103/S1068367418030084
- ID: 230481
Citar
Resumo
The effect of xymedon hydrochloride on the immune response of rabbits immunized with the rabies vaccine prepared from strain Shchelkovo-51 under the influence of immunosupression induced by cyclophosphamide has been studied. Xymedon hydrochloride was injected at a dose of 5 mg kg body weight in a volume of 1 cm3 twice a day in combination with the rabies vaccine. In addition, the immune response higher level of 1: 12800 was observed in the immunosupressed animals compared to 1: 6400 in the control animals immunized without the immunostimulant. At 6 months after vaccination, the antibody concentration of 1: 93.75 ± 44.68 remaining below the protective level was recorded, which indicated the weakness of the humoral link in the immune system. The counts of T- lymphocytes, B-lymphocytes, T-helpers, and T-suppressors in the blood of the immunesuppressed rabbits immunized with the rabies vaccine in combination with xymedon hydrochloride increased 3.2-fold, 1.9-fold, 7.7-fold, and 22.0-fold, respectively, when compared with the reference values. Therefore, the protective effect was followed by increasing the antigeninduced and spontaneuous lymphocyte proliferation, the numbers of T-helper cells and T lymphocytes exhibiting the cytotoxic and suppressive activity, and the virus-specific neutralizing antibody titers in cases wherein the Shchelkovo-51 vaccine in combination with xymedon hydrochloride was administered. It should be reasonable to apply the two-step rabies vaccination with the use of the immunostimulant, in particular, xymedon hydrochloride, to ensure the adequate immune response in immunodeficient animals.
Palavras-chave
Sobre autores
Yu. Kalmykova
Federal Center for Toxicologic, Radiative, and Biologic Safety
Email: marina-2004r@mail.ru
Rússia, Kazan, 420075
R. Akhmadeev
Federal Center for Toxicologic, Radiative, and Biologic Safety
Email: marina-2004r@mail.ru
Rússia, Kazan, 420075
M. Efimova
Federal Center for Toxicologic, Radiative, and Biologic Safety
Autor responsável pela correspondência
Email: marina-2004r@mail.ru
Rússia, Kazan, 420075
G. Murtazina
Kazan State Medical University
Email: marina-2004r@mail.ru
Rússia, Kazan, 420012
K. Papunidi
Federal Center for Toxicologic, Radiative, and Biologic Safety
Email: marina-2004r@mail.ru
Rússia, Kazan, 420075
A. Chernov
Federal Center for Toxicologic, Radiative, and Biologic Safety
Email: marina-2004r@mail.ru
Rússia, Kazan, 420075
G. Sagdeeva
Federal Center for Toxicologic, Radiative, and Biologic Safety
Email: marina-2004r@mail.ru
Rússia, Kazan, 420075
Arquivos suplementares
